Early detection of prostate cancer is vital to successful treatment. Most prostatic cancers are initially detected through a test that measures the Prostate Specific Antigen (PSA), and a Digital Rectal Exam (DRE).
Higher PSA levels can be associated with prostate inflammation, enlargement, or prostate cancer. An elevated level does not necessarily mean cancer. Often a higher PSA level can show that the prostate cancer is in its later stages and may have spread. Together, the PSA blood test and Digital Rectal Exam (DRE) are used as tools to detect cancer.
The PSA level is measured through a blood test. A DRE is a gloved-finger examination of the prostate through the rectum. Both tests help screen for prostate cancer. The only conclusive form of detection is biopsy. This usually is done with the aid of ultrasound.
Prostate Cancer Screening & Detection To detect prostate cancer early, the American Cancer Society advises ...
Prostate Cancer Risks and Warning Signs Most prostatic cancers are initially detected through an elevated prostate specific antigen (PSA) test and a digital rectal exam (DRE) ...
Prostate Cancer Staging and Grading The Gleason scale is the most common scale used for grading prostate cancer. This system ...
About The Vattikuti Urologic Institute At the Vattikuti Urology Institute, patients have access to the nation's most innovative technology and surgical techniques. Several clinics and programs are renown for their dedication and success in treating specific urologic disorders ...
Video: New Prostate Cancer Surgery Has Few Side Effects
The Vattikuti Institute Prostatectomy developed at Henry Ford and taught to surgeons around the world for prostate cancer treatment.
Surgeons at the Vattikuti Urology Institute have performed more Robotic Prostatectomy procedures to treat prostate cancer than any other hospital or medical center in the world. The procedure, fast-becoming the gold standard for the treatment of prostate cancer, was developed and perfected here. Many of the surgeons around the world performing this procedure were trained at the Vattikuti Urology Institute. (More...)
Surgeons at Henry Ford Hospital's Vattikuti Urology Institute have developed a new technique of nerve-sparing robotic prostatectomy - the veil of aphrodite - that results in significantly better erectile function outcomes than in those who receive conventional nerve-sparing surgery - without compromising cancer control. (More...)
